Fact CheckerSign in

NCT05947799Completed

A Comparative Study on the Effectiveness of Video vs Text-Based Education in Heart Failure

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

This is a study seeking to compare the change in overall heart failure (HF) knowledge score and participant preference between video-based and text-based HF education modules. Participants will be randomized to watching and reading different combinations of video-based education modules and text-based education modules. Participants will be asked to answer questions about their familiarity with heart failure medications and management before and after the said education modules.

Status (registry)
Completed
Study type
Interventional
Enrollment
130 (actual)
First submitted
9 Jul 2023
Start date
20 Jun 2023
Primary completion date
30 May 2024
Lead sponsor
Stanford University
NCT number
NCT05947799

What you commit to

  • Study type: Interventional
  • Participants enrolled: 130
  • From 20 Jun 2023 to the primary completion date, 30 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Participants who have the inability to independently read or answer written questions in English and are non-conversant in English

Who the study is looking for

  • Participants with heart failure with reduced ejection fraction (EF \<50%)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford Hospital & Clinics
Coordinator of this site? Confirm its status
StanfordUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.